Liu S - Search Results

1

CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor.

Zhu B, Qi L, Liu S, Liu W, Ou Z, Chen M, Liu L, Zu X, Wang J, Li Y. Zhu B, et al. Among authors: liu l, liu s, liu w. BMC Cancer. 2017 Feb 6;17(1):105. doi: 10.1186/s12885-017-3101-3. BMC Cancer. 2017. PMID: 28166762 Free PMC article.

2

Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma.

Liu S, Qi L, Yu Q, Song Y, Han W, Zu X, Jiang S, Yuan J, Zeng F, Xie Y. Liu S, et al. Tumour Biol. 2014 Aug;35(8):8281-8. doi: 10.1007/s13277-014-2058-y. Epub 2014 May 23. Tumour Biol. 2014. PMID: 24852427

3

Primary gastrointestinal stromal tumor of the prostate: A case report and literature review.

Liu S, Yu Q, Han W, Qi L, Zu X, Zeng F, Xie Y, Liu J. Liu S, et al. Among authors: liu j. Oncol Lett. 2014 Jun;7(6):1925-1929. doi: 10.3892/ol.2014.1968. Epub 2014 Mar 12. Oncol Lett. 2014. PMID: 24932260 Free PMC article.

4

Malignant priapism secondary to isolated penile metastasis from a renal pelvic carcinoma.

Liu S, Zeng F, Qi L, Jiang S, Tan P, Zu X, Xie Y, Han W. Liu S, et al. Can Urol Assoc J. 2014 Jul;8(7-8):E558-60. doi: 10.5489/cuaj.1695. Can Urol Assoc J. 2014. PMID: 25210564 Free PMC article.

5

Overexpression of wip1 is associated with biologic behavior in human clear cell renal cell carcinoma.

Liu S, Qi L, Han W, Wan X, Jiang S, Li Y, Xie Y, Liu L, Zeng F, Liu Z, Zu X. Liu S, et al. Among authors: liu z, liu l. PLoS One. 2014 Oct 15;9(10):e110218. doi: 10.1371/journal.pone.0110218. eCollection 2014. PLoS One. 2014. PMID: 25334029 Free PMC article.

6

Recurrent waist tumor subsequent to percutaneous nephrolithotomy: A case report.

Jiang S, Liu S, Tan P, Song T, Xie YU, Zeng F, Liu Z, Han W, Mo Z, Qi L. Jiang S, et al. Among authors: liu z, liu s. Oncol Lett. 2015 Jul;10(1):297-300. doi: 10.3892/ol.2015.3175. Epub 2015 May 4. Oncol Lett. 2015. PMID: 26171018 Free PMC article.

7

MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.

Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C, Zhang C. Chen W, et al. Among authors: liu s. J Exp Clin Cancer Res. 2016 May 10;35:76. doi: 10.1186/s13046-016-0357-4. J Exp Clin Cancer Res. 2016. PMID: 27164951 Free PMC article.

8

MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma.

Chen C, Jiang J, Fang M, Zhou L, Chen Y, Zhou J, Song Y, Kong G, Zhang B, Jiang B, Li H, Peng C, Liu S. Chen C, et al. Among authors: liu s. J Cancer. 2020 Mar 5;11(11):3216-3224. doi: 10.7150/jca.41492. eCollection 2020. J Cancer. 2020. PMID: 32231727 Free PMC article.

9

S100A family is a group of immune markers associated with poor prognosis and immune cell infiltration in hepatocellular carcinoma.

Qi Y, Zhang Y, Li J, Cai M, Zhang B, Yu Z, Li Y, Huang J, Chen X, Song Y, Liu S. Qi Y, et al. Among authors: liu s. BMC Cancer. 2023 Jul 7;23(1):637. doi: 10.1186/s12885-023-11127-3. BMC Cancer. 2023. PMID: 37420211 Free PMC article.

10

Tangeretin inhibits hepatocellular carcinoma proliferation and migration by promoting autophagy-related BECLIN1.

Zheng J, Shao Y, Jiang Y, Chen F, Liu S, Yu N, Zhang D, Liu X, Zou L. Zheng J, et al. Among authors: liu x, liu s. Cancer Manag Res. 2019 Jun 6;11:5231-5242. doi: 10.2147/CMAR.S200974. eCollection 2019. Cancer Manag Res. 2019. Retraction in: Cancer Manag Res. 2023 Nov 16;15:1321-1322. doi: 10.2147/CMAR.S450005 PMID: 31239776 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78,248 results

Search Page

Filters